Import Alert 54-13 lets FDA detain dietary supplements and bulk dietary ingredients that contain ephedrine alkaloids, from any country, without examining them. FDA banned these supplements in 2004 after linking them to heart attack, stroke and death. Any product whose label lists ephedra, ma huang or another listed plant can be held. Release needs proof it is free of ephedrine alkaloids.
Listed on 54-13? Send us the product, label and FDA notice. We review the ingredients and plan the lab evidence.
Get a 54-13 Case Review| Item | Import Alert 54-13 |
|---|---|
| Official title | DWPE of Dietary Supplements and Bulk Dietary Ingredients Containing Ephedrine Alkaloids From All Countries |
| Basis | Final rule, 69 FR 6787 (February 11, 2004), effective April 12, 2004 |
| Alkaloids | Ephedrine, pseudoephedrine, norephedrine, methylephedrine, norpseudoephedrine, methylpseudoephedrine |
| Charge | Section 402(f)(1)(A), refusal under 801(a)(3); code EPHEDALK |
| Scope | All countries; no firm list |
| Release | Lab worksheets or certificates of analysis showing no ephedrine alkaloids |
Details follow the current text of Import Alert 54-13, published February 21, 2025.
Supplements claiming ephedrine alkaloids from a botanical source.
Labels naming any of the six alkaloids from a plant source.
Labels declaring a listed Ephedra species or its extract.
Dietary ingredients for supplement use with the same labeling.
Ma huang, mahuang, Ephedrae Herba and similar names.
Herbal and botanical products under 54 E, 54 F and 54 Y codes.
| Species | Common names on the alert |
|---|---|
| Ephedra sinica | Chinese ephedra, ma huang, cao ma huang, mao |
| Ephedra equisetina | Mongolian ephedra, mu zei ma huang, mahwang |
| Ephedra intermedia | Zhong ma huang, ma huang gen (root) |
| Ephedra distachya | Jointfir, sea-grape, shuang sui ma huang |
| Ephedra helvetica | Listed by scientific name |
FDA notes spelling variants such as joint fir, joint-fir, ma-huang and mahuang. Products labeled or promoted to treat disease are drugs and may face other alerts.
A detained product or bulk ingredient may be released if the firm provides documentary evidence, such as lab worksheets or certificates of analysis, showing it is free of ephedrine alkaloids. Send it to the FDA Division compliance office in the notice. If the product contains them, the outcome is export or destruction.
The alert applies to all countries and has no firm list, so there is no Red List removal. The real fix is reformulation: remove Ephedra and any ephedrine alkaloid source, correct the label and keep lab evidence for every lot. General guidance is in RPM Chapter 9-8.
Need samples pulled and tested for a detained supplement shipment? Our sister company, FDA Detention Sampling, coordinates sample collection, chain of custody and testing with LAAF-accredited laboratories nationwide. Call +1 (786) 561-3726.
FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.
Removal help for food and supplements.
Supplements with hidden drugs.
New dietary ingredients.
Kratom supplements.
Check claims and ingredient labeling.
Supplement registration and labeling.
We review the ingredients against FDA's plant list, coordinate testing for ephedrine alkaloids and prepare the release request. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.
Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.
Get a 54-13 Case ReviewFDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.
Import Alert 54-13 is titled "Detention Without Physical Examination of Dietary Supplements And Bulk Dietary Ingredients Containing Ephedrine Alkaloids From All Countries."
FDA's final rule (69 FR 6787, February 11, 2004) declared them adulterated because they present an unreasonable risk of serious adverse events, including heart attack, stroke and death. It took effect April 12, 2004.
Ephedrine, pseudoephedrine, norephedrine, methylephedrine, norpseudoephedrine and methylpseudoephedrine.
Ephedra distachya, Ephedra helvetica, Ephedra equisetina, Ephedra intermedia and Ephedra sinica, with common names such as ma huang, Chinese ephedra, Mongolian ephedra, jointfir and Ephedrae Herba.
When the label claims ephedrine alkaloids or one of the six alkaloids from a botanical source, or declares one of the listed plants or its extract. This applies to supplements and to bulk dietary ingredients.
The product appears to contain ephedrine alkaloids, which present an unreasonable risk of illness or injury. It is adulterated under section 402(f)(1)(A) and subject to refusal under section 801(a)(3). The code is EPHEDALK.
Yes. It covers products from all countries, and there is no list of firms.
Check your label against Import Alert 54-13. If it lists Ephedra, ma huang, any listed species or any of the six alkaloids from a plant source, FDA can detain it.
Provide documentary evidence, such as lab worksheets or certificates of analysis, showing the product or bulk ingredient is free of ephedrine alkaloids. Send it to the FDA Division compliance office in the notice.
Only if lab evidence shows it is free of ephedrine alkaloids. In practice, a label that declares ma huang will keep getting detained, so the label and formula need to change.
No. The alert has no firm list, so there is nothing to be removed from. The fix is to reformulate without ephedrine alkaloid sources and keep lab evidence. General guidance is in RPM Chapter 9-8.
No. Products with ephedrine are not lawful dietary supplements, and products promoted as drugs fall under FDA's drug rules. Questions on drug products go to CDERImports@fda.hhs.gov.
FDA notes variants such as joint fir, joint-fir, ma-huang and mahuang. All are treated as the same plant names.
The alert lists the Division of Import Operations at (301) 796-0356 or Imports@fda.hhs.gov, FDAPRIVATELABIMPORTALERTS@fda.hhs.gov for method questions, HFP-OCE-Imports@fda.hhs.gov for food policy questions and CDERImports@fda.hhs.gov for drug products.
No. FDA makes every admissibility decision. We are an independent compliance firm, not FDA or a law firm. We help you build complete, well-documented evidence.
Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.
Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.